前往化源商城

102043-42-5

102043-42-5结构式
102043-42-5结构式

化源商城直购

英文名 (5α,8β)-3-Methoxy-17-methyl-6,7-didehydro-4,5-epoxymorphinan-8-ol hydrochloride (1:1)
英文别名 PGE2 1,15-lactone
(1R,2R,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-2,3-diol
(1R,2R,3S,4R)-2,6,6-trimethylcyclo[3.1.1]heptane-2,3-diol
(-)-podorhizol
(-)epi-podorhizol
(-)-pinane-2,3-diol
(-)-prostaglandin E2-1,15-lactone
Pinanediol [INCI]
(-)-2,3-Pinanediol
(1R,2R,3S,5R)-(-)-Pinanediol
(1R,2R,3S,5R)-(-)-2,3-Pinanediol
(-)-cis-Pinane-cis-2,3-diol
(3S,11aR,14R,14aR)-14-hydroxy-3-pentyl-6,7,8,11,11a,13,14,14a-octahydro-3H-cyclopenta[e]oxacyclotridecine-5,12-dione
(1R,2R,3S,5R)-2,6,6-trimethylbicyclo[3.3.1]heptane-2,3-diol
(-)-(1R,2R,3S,5R)-pinane-2,3-diol
(-)-pinanediol
(-)-pseudocodeine,hydrochloride
[1R-(1|A,2|A,3|A,5|A)]-2,6,6-Trimethylbicyclo[3.1.1]heptane-2,3-diol
(-)-Pseudocodein,Hydrochlorid
(-)-2-Hydroxyisopinocampheol
沸点 466ºC at 760mmHg
分子式 C18H22ClNO3
分子量 335.82500
闪点 235.7ºC
精确质量 335.12900
PSA 41.93000
LogP 2.24100
蒸汽压 1.74E-09mmHg at 25°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QD1055000
CHEMICAL NAME :
Morphinan-8-beta-ol, 6,7-didehydro-4,5-alpha-epoxy-3-methoxy-17-methyl-, hydrochloride
CAS REGISTRY NUMBER :
102043-42-5
LAST UPDATED :
199009
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C18-H21-N-O3.Cl-H
MOLECULAR WEIGHT :
335.86
WISWESSER LINE NOTATION :
T B6566 B6/CO 4ABBC R BX HO PN EU GHT&&TTJ DQ JO1 P1 &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - muscle weakness
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 51,35,1934
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
579 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 66,182,1939